Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy.
Author(s): Marfo K, Chapochnick-Friedmann J, Akalin E, Lu A
Affiliation(s): Department of Pharmacy, Montefiore Medical Center, Bronx, New York, New York 10467, USA.
Publication date & source: 2009-12, Transplant Proc., 41(10):4411-3.
Publication type: Case Reports
Solid organ transplant recipients undergoing immunosuppressive therapy are considered to be at high risk for serious infectious complications. Recently in the United States, a pandemic of H1N1 flu infection has been reported with serious complications. We describe H1N1 infection in a living kidney donor and the 42-year-old kidney transplant recipient exposed to this kidney donor and undergoing intense immunosuppressive therapy. Postexposure prophylaxis with oseltamivir was effective to prevent H1N1 influenza A virus in a donor and a recipient.
|